Extension Study Data Supporting Long-Term Safety and Efficacy of Eloctate®...
CAMBRIDGE, Mass. & STOCKHOLM Newly published clinical data demonstrate that people on extended-interval prophylaxis regimens with ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion...
View ArticleResolutionMD® Medical Imaging Software Now Registered for Web and Mobile...
CALGARY, Alberta Calgary Scientific Inc., a company known for creating innovative technology for the medical industry and beyond, announced today that ResolutionMD® medical imaging software is now...
View ArticleTL Plastic Surgery Korea Holds the Key to Small Face for Hong Kong
SEOUL, South Korea Ever since the small and slim face came into the limelight as a standard of beauty, larger number of people visited plastic surgery clinic to solve the big-face-problems....
View ArticleTL Plastic Surgery Korea, Small Face Solution for Singapore Is Now Here!
SEOUL, South Korea Ever since the small and slim face came into the limelight as a standard of beauty, larger number of people visited plastic surgery clinic to solve the big-face-problems....
View ArticleRTLS Leader Sonitor Technologies Signs Distribution Agreement with Hills...
STAMFORD, Conn. Sonitor Technologies, the global RTLS technology leader, announced today that it has signed a distribution agreement with Hills Health Solutions to expand the availability of...
View ArticleMolex Delivers ISO 13485-Compliant, Medical-Grade Surgical Cables from Its...
LISLE, Ill. Molex, LLC operates a fully ISO 146441-1:1999 Class 8-certified clean room, satisfying strict particulate contamination levels specified by ISO-compliant requirements. Located in...
View ArticleAmneal Announces New Biosciences Unit with Charles Lucarelli as President
BRIDGEWATER, N.J. Amneal today announced the creation of Amneal Biosciences, a wholly-owned subsidiary of Amneal Pharmaceuticals LLC (www.amneal.com). Amneal Biosciences will focus exclusively on...
View Article巴西A.C.Camargo癌症中心采用Masimo SpHb用于血红蛋白的无创连续监测
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天宣布,巴西圣保罗A.C.Camargo癌症中心 已安装Masimo的无创连续血红蛋白(SpHb®)技术来监测手术患者。...
View ArticleブラジルのACカマルゴがんセンターが非侵襲的・連続的ヘモグロビン測定でマシモのSpHb技術を導入
スイス・ヌーシャテル (ビジネスワイヤ) — マシモ(NASDAQ: MASI)は本日、ブラジル・サンパウロのACカマルゴがんセンターが外科患者をモニタリングするためにマシモの非侵襲的・連続的ヘモグロビン(SpHb®)測定技術を導入したと発表しました。...
View ArticleFirst Australian and Asia/Pacific Hospital to Demonstrate Commitment to New...
MELBOURNE, Australia Alfred Health Radiation Oncology (AHRO), based at The William Buckland Radiotherapy Centre, announced today that it has become the first cancer centre in the Asia and Pacific...
View ArticleH.Lundbeck A/S: Experts Call for Urgent Action to Better Diagnose Severe Form...
LONDON A new report launched today, ‘Paying the ultimate price’, highlights the urgent need for accurate diagnosis and management of bipolar I disorder in order to address a significant burden on...
View ArticleDynoSense Enters Marketing and Distribution Partnership with Chinese Health...
SUNNYVALE, Calif. DynoSense Corp. has announced a strategic partnership with JKOM Cloud Health Technology Co. Ltd to bring its digital health solutions to the Chinese market. Under the terms of the...
View ArticleASE Foundation Selects Mindray as Exclusive Corporate Sponsor of Its...
HA NOI, Vietnam Mindray, one of the world’s leading developers of cardiac ultrasound technologies, is proud to announce that it was exclusively selected for the American Society of Echocardiography...
View Articleファインデックス、「Data-Connector」を従量課金型の移行ツールとして提供開始
愛媛県松山市 (ビジネスワイヤ) — 株式会社ファインデックス(東証一部:3649 本社:愛媛県松山市三番町4-9-6 社長:相原輝夫)は、Screen Based EAIツール「Data-Connector」を新たにデータ移行量に合わせた従量課金型のデータ移行ツールとして提供開始しました。...
View ArticleiMDsoft to Present Its Advanced Anaesthesia Information Management Solution...
BRISBANE, Australia iMDsoft will be presenting MetaVision Anaesthesia™ at the ASA & NZSA Combined Scientific Congress 2015 in Darwin from 12-15 September. MetaVision Anaesthesia is an advanced...
View ArticleNovocure Announces Optune Now Available at more than 200 Leading Cancer...
NEW YORK Novocure announced today that more than 200 treatment centers in the United States have been certified to prescribe Optune to patients with recurrent glioblastoma (GBM). GBM is the most...
View ArticleAstraZeneca Presents Further Evidence for the Potential of AZD9291 in...
LONDON AstraZeneca today announced updated data on AZD9291 in first-line patients with epidermal growth factor receptor mutation (EGFRm) positive advanced non-small cell lung cancer (NSCLC) and...
View ArticleAcelity Partners with GHD to Expand Access to Advanced Wound Dressing...
SAN ANTONIO Acelity, a global wound care and regenerative medicine company, today announced that it has entered into a strategic commercial partnership with GHD GesundHeits GmbH Deutschland (GHD) to...
View ArticleU.S. FDA Accepts First Digital Medicine New Drug Application for Otsuka and...
TOKYO & REDWOOD CITY, Calif. Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Proteus Digital Health (Proteus) today announced that the United States Food and Drug Administration (FDA) has...
View Article